Back to Authors

Muralidharan, Rajanandini

https://orcid.org/0000-0002-1656-7357

Mayo Clinic

University of Pennsylvania

Citations 5

Reported Use of IV-Tissue Plasminogen Activator (IV-TPA) for Acute Ischemic Stroke (AIS) Worldwide: A Systematic Review (S09.002)
Berkowitz, Aaron L., McLane, Hannah, Shen, Gordon C , Lyons, Jennifer , Mittal, Manoj , Muralidharan, Rajanandini , Shinohara, Russell Taki , Shuaib, Ashfaq M , Mateen, Farrah J.

Neurology | December 7, 2023 | Volume: 80 | Issue: 7_supplement | Pages: No page available

10.1212/wnl.80.7_supplement.s09.002 Get It

Predictors of Poor Outcome in Adult Patients with Fulminant Bacterial Meningitis (P04.017)
Muralidharan, Rajanandini , Mateen, Farrah J. , Rabinstein, Alejandro A.

Neurology | December 7, 2023 | Volume: 80 | Issue: 7_supplement | Pages: No page available

10.1212/wnl.80.7_supplement.p04.017 Get It

Reported Use of IV-Tissue Plasminogen Activator (IV-TPA) for Acute Ischemic Stroke (AIS) Worldwide: A Systematic Review (IN7-2.001)
Berkowitz, Aaron L., McLane, Hannah, Shen, Gordon C , Lyons, Jennifer , Mittal, Manoj , Muralidharan, Rajanandini , Shinohara, Russell Taki , Shuaib, Ashfaq M , Mateen, Farrah J.

Neurology | December 7, 2023 | Volume: 80 | Issue: 7_supplement | Pages: No page available

10.1212/wnl.80.7_supplement.in7-2.001 Get It

Posterior reversible encephalopathy syndrome is not associated with mutations in aquaporin-4
Matiello, Marcelo , Muralidharan, Rajanandini , Sun, David, Weinshenker, Brian G. , Rabinstein, Alejandro A. , Weinshenker, Brian G

Neurology Genetics | August 27, 2015 | Volume: 1 | Issue: 2 | Pages: No page available

10.1212/nxg.0000000000000013 Get It

Outcome of fulminant bacterial meningitis in adult patients
Mateen, Farrah J. , Muralidharan, Rajanandini , Rabinstein, Alejandro A. , Mateen, Farrah

European Journal of Neurology | December 19, 2013 | Volume: 21 | Issue: 3 | Pages: 447-453

10.1111/ene.12328 Get It

Background and purposeThe objective of our study was to identify neurological factors associated with poor outcome in adult patients with fulminant bacterial meningitis.MethodsThis was a retrospective review of consecutive adult patients with fulminant bacterial meningitis, defined as meningitis causing coma within 24–48 h of hospitalization, at Mayo Clinic Rochester between January 2000 and November 2010. Functional status was assessed at discharge and upon last follow‐up using the modified Rankin scale (mRS). The primary end‐point was death or new major disability (increase of >2 on the mRS) at last follow‐up.ResultsThirty‐nine patients were identified. Encephalopathy (44%), coma (28%), focal seizures (3%) or a combination of these (26%) were present on admission. The most common pathogen was Streptococcus pneumoniae (57%). All patients were treated with broad spectrum antibiotics and 51% received steroids. Serious systemic complications were seen in 23 patients. Sixteen patients (41%) died during hospitalization. Median mRS at hospital discharge for surviving patients was 3; four patients had new major disability with a mean follow‐up of 11 months. Predictors of death or new major disability included lower Glasgow Coma Scale score at nadir [P = 0.002; age‐ and sex‐adjusted odds ratio (OR) 0.46, 95% confidence interval (CI) 0.28–0.48], longer duration of symptoms before hospitalization (P = 0.045; adjusted OR 2.34, 95% CI 1.02–5.37), abnormal head imaging at presentation (P = 0.008; adjusted OR 9.40, 95% CI 1.78−49.6) and use of intracranial pressure monitoring (P = 0.010, adjusted OR 51.0, 95% CI 2.51−1036).ConclusionMany adult patients who survive hospitalization are able to regain their pre‐morbid level of function. Aggressive management of bacterial meningitis is justified even in comatose adult patients.